Clinical Trials Browser

Phase 2 × Colitis, Ulcerative × Clear all

Adenocarcinoma Of Esophagus, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Colitis, Ulcerative, Colonic Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Melanoma

NCT04767984 2026-01-21

Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis

Phase 2 Active not recruiting

42 enrolled

Gastrointestinal

Colitis, Ulcerative, Colorectal Neoplasms

NCT03760003 2025-11-28

Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis

Phase 2 Completed

355 enrolled 39 charts

Colitis, Ulcerative

NCT05785715 2025-07-01

Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis

Phase 2 Terminated

81 enrolled

Lymphoid

Colitis, Ulcerative, Lymphoma, Follicular

NCT05156125 2024-11-13

VTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis

Phase 2 Active not recruiting

213 enrolled 19 charts

Lymphoid

Colitis, Ulcerative, Lymphoma, Follicular

NCT03944447 2022-06-02

OMNI-Can

Phase 2 Unknown

200,000 enrolled

Classical hematology

Chronic Traumatic Encephalopathy, Brain Injuries, Traumatic, COVID-19, Acquired Immunodeficiency Syndrome, Amyotrophic Lateral Sclerosis, Anemia, Sickle Cell, Anxiety Disorders, Autistic Disorder, Bipolar Disorder, Colitis, Ulcerative, Crohn Disease, Depression, Epilepsy, Fibromyalgia, Tourette Syndrome, Glaucoma, Hepatitis C, Sleep Initiation and Maintenance Disorders, Multiple Sclerosis, Opioid-Related Disorders, Neoplasms, Parkinson Disease, Seizures, Stress Disorders, Post-Traumatic, Inflammatory Bowel Diseases, Coronavirus Infections, Severe Acute Respiratory Syndrome, Chronic Pain

NCT01520324 2019-02-08

Neoplasia Detection With Methylene Blue MMX Tablets in Patients With UC Undergoing Colonoscopy

Phase 2 Completed

53 enrolled 13 charts

Colitis, Ulcerative

NCT01959282 2019-01-04

A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis

Phase 2 Completed

219 enrolled

Lymphoid

Colitis, Ulcerative, Lymphoma, Follicular, Motor Activity

NCT00727324 2012-04-02

Safety/Efficacy Study of Bovine Intestinal Alkaline Phosphatase in Patients With Moderate to Severe Ulcerative Colitis

Phase 2 Completed

22 enrolled

LymphoidOther

Colitis, Ulcerative, Lymphoma, Follicular, Mucositis

NCT00676832 2010-09-29

Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis

Phase 2 Completed

190 enrolled

Lymphoid

Colitis, Colitis, Ulcerative, Lymphoma, Follicular, Ulcer

NCT00152841 2009-03-17

Effect of Iron and Vitamin E Supplementation on Disease Activity in Patients With Either Crohn's Disease or Ulcerative Colitis

Phase 2 Terminated

30 enrolled

Lymphoid

Colitis, Ulcerative, Crohn Disease, Lymphoma, Follicular

Clinical Trials

PSI-Immune

Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis

Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis

Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis

VTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis

OMNI-Can

Neoplasia Detection With Methylene Blue MMX Tablets in Patients With UC Undergoing Colonoscopy

A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis

Safety/Efficacy Study of Bovine Intestinal Alkaline Phosphatase in Patients With Moderate to Severe Ulcerative Colitis

Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis

Effect of Iron and Vitamin E Supplementation on Disease Activity in Patients With Either Crohn's Disease or Ulcerative Colitis